The "Global Antisense and RNAi Therapeutics Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
The antisense and rnai therapeutics market is poised to grow by $ 1.61 bn during 2021-2025 progressing at a CAGR of 8% during the forecast period.
The market is driven by the high target affinity and specificity of RNAi therapeutics and availability of delivery platforms like nanoparticles and conjugates.
The report on antisense and rnai therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.
This study identifies ease of standardization and large-scale manufacturing as one of the prime reasons driving the antisense and rnai therapeutics market growth during the next few years. ease of standardization and large-scale manufacturing will lead to sizable demand in the market.
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antisense and rnai therapeutics market vendors that include Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Bausch Health Companies Inc., Biogen Inc., Boehringer Ingelheim International GmbH, Dicerna Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Sanofi, and Sarepta Therapeutics Inc..
Also, the antisense and rnai therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Key Topics Covered:
Value chain analysis
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
Five forces analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market Segmentation by Type
Comparison by Type
Antisense therapy - Market size and forecast 2020-2025
RNAi therapy - Market size and forecast 2020-2025
Market opportunity by Type
Market Segmentation by Application
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity by geography
Market positioning of vendors
Alnylam Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Bausch Health Companies Inc.
Boehringer Ingelheim International GmbH
Dicerna Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc.
Sarepta Therapeutics Inc.
Scope of the report
Currency conversion rates for US$
List of abbreviations
List of Exhibits
For more information about this report visit https://www.researchandmarkets.com/r/6j3w73
View source version on businesswire.com: https://www.businesswire.com/news/home/20210225005765/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900